The overall 5-year relative survival rate for AML is about 30%, but this number is an estimate based on a large group of people and does not predict individual outcomes. Younger people with AML tend ...

AML is a genetically heterogeneous disease, particularly in older patients. In patients older than 60 years, survival rates are variable after the most important curative approach, intensive ...

Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are cancers of the blood and bone marrow. The main difference between the two is the type of white blood cell they impact. In AML, ...

Acute myeloid leukemia (AML) is a cancer that occurs in the blood and bone marrow. In its early stages, the symptoms of AML may resemble the flu, and you may have a fever and fatigue. Treatment for ...

As consolidation therapy for acute myeloid leukemia (AML), allogeneic hematopoietic stem-cell transplantation provides a benefit in part by means of an immune-mediated graft-versus-leukemia effect. We ...

As someone with acute myeloid leukemia (AML), the best choice you can make is to receive care at an academic medical center, like Fred Hutch Cancer Center, from physicians who specialize in AML.

The panel reached ≥97.8% consensus on AML management. The panel agreed to use international risk stratification categories for personalized treatment of AML. The presence of ≥10% blasts for recurrent ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. Led by Mikkael ...